1Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah.
2Department of Neurosurgery, University of California, San Diego, California.
J Neurosurg Pediatr. 2024 Jul 5;34(4):305-314. doi: 10.3171/2024.5.PEDS2469. Print 2024 Oct 1.
When the peritoneal cavity cannot serve as the distal shunt terminus, nonperitoneal shunts, typically terminating in the atrium or pleural space, are used. The comparative effectiveness of these two terminus options has not been evaluated. The authors directly compared shunt survival and complication rates for ventriculoatrial (VA) and ventriculopleural (VPl) shunts in a pediatric cohort.
The Hydrocephalus Clinical Research Network Core Data Project was used to identify children ≤ 18 years of age who underwent either VA or VPl shunt insertion. The primary outcome was time to shunt failure. Secondary outcomes included distal site complications and frequency of shunt failure at 6, 12, and 24 months.
The search criteria yielded 416 children from 14 centers with either a VA (n = 318) or VPl (n = 98) shunt, including those converted from ventriculoperitoneal shunts. Children with VA shunts had a lower median age at insertion (6.1 years vs 12.4 years, p < 0.001). Among those children with VA shunts, a hydrocephalus etiology of intraventricular hemorrhage (IVH) secondary to prematurity comprised a higher proportion (47.0% vs 31.2%) and myelomeningocele comprised a lower proportion (17.8% vs 27.3%) (p = 0.024) compared with those with VPl shunts. At 24 months, there was a higher cumulative number of revisions for VA shunts (48.6% vs 38.9%, p = 0.038). When stratified by patient age at shunt insertion, VA shunts in children < 6 years had the lowest shunt survival rate (p < 0.001, log-rank test). After controlling for age and etiology, multivariable analysis did not find that shunt type (VA vs VPl) was predictive of time to shunt failure. No differences were found in the cumulative frequency of complications (VA 6.0% vs VPl 9.2%, p = 0.257), but there was a higher rate of pneumothorax in the VPl cohort (3.1% vs 0%, p = 0.013).
Shunt survival was similar between VA and VPl shunts, although VA shunts are used more often, particularly in younger patients. Children < 6 years with VA shunts appeared to have the shortest shunt survival, which may be a result of the VA group having more cases of IVH secondary to prematurity; however, when age and etiology were included in a multivariable model, shunt location (atrium vs pleural space) was not associated with time to failure. The baseline differences between children treated with a VA versus a VPl shunt likely explain current practice patterns.
当腹腔无法作为远端分流末端时,通常会使用非腹腔分流,其末端通常终止于心房或胸腔。尚未评估这两种末端选择的比较效果。作者在儿科队列中直接比较了脑室心房(VA)和脑室胸膜(VPl)分流的分流器存活率和并发症发生率。
使用脑积水临床研究网络核心数据项目确定了≤ 18 岁接受 VA 或 VPl 分流植入术的儿童。主要结果是分流器失效时间。次要结果包括远端部位并发症和分流器在 6、12 和 24 个月时失效的频率。
搜索标准从 14 个中心确定了 416 名儿童,他们接受了 VA(n = 318)或 VPl(n = 98)分流,包括那些从脑室腹腔分流转换而来的儿童。VA 分流器的儿童插入时的中位年龄较低(6.1 岁对 12.4 岁,p < 0.001)。在接受 VA 分流的儿童中,由早产引起的脑室内出血(IVH)引起的脑积水病因占较高比例(47.0%对 31.2%),而脊髓脊膜膨出的比例较低(17.8%对 27.3%)(p = 0.024)。与接受 VPl 分流的儿童相比。在 24 个月时,VA 分流器的修订次数更高(48.6%对 38.9%,p = 0.038)。当按分流器插入时患儿年龄分层时,< 6 岁的 VA 分流器的分流器存活率最低(p < 0.001,对数秩检验)。在控制年龄和病因后,多变量分析并未发现分流器类型(VA 对 VPl)是分流器失效时间的预测因素。未发现并发症累积频率(VA 6.0%对 VPl 9.2%,p = 0.257)存在差异,但 VPl 队列气胸发生率更高(3.1%对 0%,p = 0.013)。
VA 和 VPl 分流器的分流器存活率相似,尽管 VA 分流器更常用,尤其是在年幼的患者中。接受 VA 分流的< 6 岁儿童似乎有最短的分流器存活时间,这可能是由于 VA 组有更多因早产引起的 IVH 病例;然而,当年龄和病因被纳入多变量模型时,分流器位置(心房对胸膜腔)与失败时间无关。接受 VA 与 VPl 分流的患儿之间的基线差异可能解释了当前的治疗模式。